Gulf Pharmaceutical Industries

Last Updated:
  • 1.520 AED
  • -0.060
  • -3.80%
شركة الخليج للصناعات الدوائية
جلفار
Symbol : JULPHAR
ISIN : AEG000201018
52-Week Range : 0.730 - 1.780
Turnover Ratio : 1.04
Market : Abu Dhabi Securities Exchange
Sector : Health Care
Industry : Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :

Basic Information

  • Activity :
    Gulf Pharmaceutical Industries (known as: Julphar) is a public company, listed on Abu Dhabi Securities Exchange (ADX) since July 2005. Julphar operates within the Pharmaceuticals, Biotechnology and Life...
  • Industry Group :
    pharmaceuticals Research and Biotechnology
  • Sub-Industry :
  • ISIN :
    AEG000201018
  • Contact Person :
  • Established On:
    30-Mar-1980
  • Stock Listing On :
    20-Oct-2002
  • No of Employees :
    3,000 Employees as of 2017
  • Outstanding Shares :
    1,155,227,811
  • Free Float Shares :
  • Par Value :
  • Paid Capital :
  • Market Cap :
  • Authorized Capital :

Indices Membership

Action Date Index Provider
Join 2002 Abu Dhabi General Index Abu Dhabi Securities Exchange
Join 2002 Industrial Abu Dhabi Securities Exchange
Gulf Pharmaceutical Industries
P.O. Box: 997, Digdaga, Ras Al Khaimah, UAE
T : +971 7 2461461
F : +971 7 2462462
www.julphar.net
info@julphar.net

Management

Title Name As Of
Chairman: Saqr Al Qasimi 2019
CEO: Essam Ahmed 2020
Deputy Chairman: Rabih Khouri 2021
Board Member: Abdulaziz Alzaabi 2019
Medhat Abo AlAsrar 2019
Raman Garg 2020
Abboud Bejjani 2020
Olfa Gam 2021
Jean Diab 2023
Hamodi Al Limy

Reports

Date Title File
2024 Julphar Quarterly Financials Report Q2 2024
2024 Julphar Reports strong Q2 2024 Financial Results
2024 Julphar Quarterly Financials Report Q1 2024
2024 Julphar Annual Financials Report 2023
2023 Julphar Quarterly Financials Report Q3 2023
2023 Julphar Quarterly Financials Report Q2 2023
2023 Julphar Quarterly Financials Report Q1 2023
2023 Julphar Annual Financials Report 2022
2022 Julphar announces robust Q2 2022 results marking a return to profitability
2022 Julphar Quarterly Financials Report Q2 2022
2022 Gulf Pharmaceutical Industries Julphar announces Q1 2022 results; delivers robust top and bottom-line growth
Check our coverage for